Evaluation of 18F-FPPA as a Positron Emission Tomography Radioligand for Imaging CSF1R in LPS-Induced Rat Model of Neuroinflammation.

Fu Z, Lin Q, Wang Z, Su H, Hu Z, Zhang H, Sheng R, Wang C, Cheng D

Open source

DOI
10.1021/acs.molpharmaceut.6c00276
Published
2026 Sep 7
Container
Molecular pharmaceutics
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1021/acs.molpharmaceut.6c00276,
  title = {Evaluation of 18F-FPPA as a Positron Emission Tomography Radioligand for Imaging CSF1R in LPS-Induced Rat Model of Neuroinflammation.},
  author = {Fu Z and Lin Q and Wang Z and Su H and Hu Z and Zhang H and Sheng R and Wang C and Cheng D},
  year = {2026},
  journal = {Molecular pharmaceutics},
  doi = {10.1021/acs.molpharmaceut.6c00276},
  url = {https://doi.org/10.1021/acs.molpharmaceut.6c00276}
}

RIS

TY  - JOUR
TI  - Evaluation of 18F-FPPA as a Positron Emission Tomography Radioligand for Imaging CSF1R in LPS-Induced Rat Model of Neuroinflammation.
AU  - Fu Z
AU  - Lin Q
AU  - Wang Z
AU  - Su H
AU  - Hu Z
AU  - Zhang H
AU  - Sheng R
AU  - Wang C
AU  - Cheng D
PY  - 2026
JO  - Molecular pharmaceutics
DO  - 10.1021/acs.molpharmaceut.6c00276
UR  - https://doi.org/10.1021/acs.molpharmaceut.6c00276
ER  - 

APA

Z, F., Q, L., Z, W., H, S., Z, H., H, Z., R, S., C, W., & D, C. (2026). Evaluation of 18F-FPPA as a Positron Emission Tomography Radioligand for Imaging CSF1R in LPS-Induced Rat Model of Neuroinflammation.. Molecular pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.6c00276

Source records